Patient Worthy(@PatientWorthy) 's Twitter Profileg
Patient Worthy

@PatientWorthy

We're a resource for engaging, informative content and rare patient news, well done.

ID:3166193421

linkhttp://patientworthy.com/ calendar_today14-04-2015 16:35:25

25,2K Tweets

8,1K Followers

7,0K Following

Xtalks Webinars(@Xtalks) 's Twitter Profile Photo

πŸ”¬ Chiesi Global Rare Diseases has received FDA approval for Filsuvez, a new topical gel containing birch triterpenes, offering hope to those living with junctional epidermolysis bullosa (JEB) and dystrophic epidermolysis bullosa (DEB). Read more here: buff.ly/3RI8dsC

account_circle